Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex...

Area of Science:

• Biochemistry
• Structural Biology
• Medicinal Chemistry

Background:

• Protein kinase CK2 (CK2) is implicated in various human diseases, notably cancer.
• CK2 is a significant target for therapeutic inhibitor development in both academic and industrial research.
• Understanding CK2's structure is crucial for designing effective drugs.

Purpose of the Study:

• To present crystal structures of CK2α and CK2α' in complex with novel ATP-competitive inhibitors.
• To investigate the structural deformations induced by these inhibitors within the ATP-binding site.
• To explore the conformational flexibility of CK2 and its implications for drug design.

Main Methods:

• X-ray crystallography was employed to determine the structures of CK2α/CK2α' bound to inhibitors.
• Two distinct inhibitor scaffolds, flavonol and thieno[2,3-d]pyrimidine, were utilized.
• Analysis of the obtained crystal structures focused on the ATP-binding loop and hinge/helix αD regions.

Main Results:

• Six crystal structures were obtained for CK2α or CK2α' complexed with two types of ATP-competitive inhibitors.
• The structures demonstrate significant conformational changes in the ATP-binding loop and hinge/helix αD regions.
• These findings highlight the capacity of synthetic ligands to stabilize unusual enzyme conformations.

Conclusions:

• The presented structures expand the understanding of CK2's conformational landscape.
• Synthetic ligands can effectively trap unique enzyme conformations.
• This provides a basis for designing a new generation of CK2 inhibitors that exploit and stabilize these conformations for therapeutic benefit.